Intravenous to oral (iv:po) anti-infective conversion therapy.
Wetzstein
G A
GA
Pharmacy Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla., USA.
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000191:economics / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000009:adverse effects; D003363:Cost Control; D003657:Decision Making; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007262:Infusions, Intravenous; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents